Crystalline forms and processes for the preparation of phenyl-pyrazoles useful as modulators of the 5-HT2A serotonin receptor

Details for Australian Patent Application No. 2007254255 (hide)

Owner Arena Pharmaceuticals, Inc.

Inventors Gharbaoui, Tawfik; Lally, Edward A.; Shah, Nainesh; Krishnan, Ashwin M.; Hart, Ryan M.; Sengupta, Dipanjan; Macias, Mark

Agent FB Rice

Pub. Number AU-A-2007254255

PCT Pub. Number WO2007/136689

Priority 60/801,789 18.05.06 US; 60/921,318 02.04.07 US

Filing date 17 May 2007

Wipo publication date 29 November 2007

International Classifications

C07D 231/12 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

A61K 31/415 (2006.01) - 1,2-Diazoles

A61P 7/00 (2006.01) Drugs for disorders of the blood or the extracellular fluid

Event Publications

25 September 2008 PCT application entered the National Phase

  PCT publication WO2007/136689 Priority application(s): WO2007/136689

3 September 2009 Amendment Made

  The nature of the amendment is: Add the co-inventor Duffield, Jonathan J.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007254258-Crystalline forms of 5-chloro-6- (2, 6-difluoro-4- [3- (methylamino) propoxy] phenyl)-N-((1S)-2, 2, 2,-trifluoro-1-methylethyl] [1,2,4] triazolo [1,5-a] pyrimidin-7-amine salts

2007254251-Methods and compositions for inactivation of dihydrofolate reductase